Status:
UNKNOWN
Intraductal Transanastomotic Stent in Duct-to-duct Biliary Reconstruction in Liver Transplantation
Lead Sponsor:
Seoul St. Mary's Hospital
Conditions:
Liver Transplant; Complications
Eligibility:
All Genders
19-70 years
Phase:
NA
Brief Summary
Liver transplant surgery has been used as a major treatment modality for end-stage liver disease, hepatocellular carcinoma and acute liver failure due to innovations in surgical treatment of donors an...
Detailed Description
Aim of study 1. Primary end-point To compare and evaluate the incidence of biliary tract complications within 6 months after surgery according to the presence or absence of an intrabiliary stent duri...
Eligibility Criteria
Inclusion
- 19 years old or older \~ under 70 years old
- Patients eligible for liver transplantation ③ Patients who have consented to written consent
Exclusion
- ① When performing hepato-plant anastomosis due to anatomical/biliary tract disease
- ② Patients who are not eligible for liver transplantation
Key Trial Info
Start Date :
November 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
276 Patients enrolled
Trial Details
Trial ID
NCT04804215
Start Date
November 25 2022
End Date
December 30 2024
Last Update
January 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of HBP Surgery, Seoul St. Mary's hospital
Seoul, Seocho-gu, Banopo-dong, South Korea, 137-701